NewAmsterdam Pharma Co. NV (NAMS)
29.33
-1.05
(-3.46%)
USD |
NASDAQ |
Jun 10, 16:00
29.30
-0.03
(-0.10%)
After-Hours: 20:00
NewAmsterdam Pharma Market Cap : 3.421B for June 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| June 10, 2026 | 3.421B |
| June 09, 2026 | 3.544B |
| June 08, 2026 | 3.610B |
| June 05, 2026 | 3.677B |
| June 04, 2026 | 3.811B |
| June 03, 2026 | 3.745B |
| June 02, 2026 | 3.699B |
| June 01, 2026 | 3.708B |
| May 29, 2026 | 3.928B |
| May 28, 2026 | 4.131B |
| May 27, 2026 | 4.274B |
| May 26, 2026 | 4.221B |
| May 22, 2026 | 4.143B |
| May 21, 2026 | 4.178B |
| May 20, 2026 | 4.179B |
| May 19, 2026 | 3.942B |
| May 18, 2026 | 3.991B |
| May 15, 2026 | 4.143B |
| May 14, 2026 | 4.311B |
| May 13, 2026 | 4.413B |
| May 12, 2026 | 4.546B |
| May 11, 2026 | 4.628B |
| May 08, 2026 | 4.528B |
| May 07, 2026 | 4.074B |
| May 06, 2026 | 3.623B |
| Date | Value |
|---|---|
| May 05, 2026 | 3.490B |
| May 04, 2026 | 3.491B |
| May 01, 2026 | 3.269B |
| April 30, 2026 | 3.284B |
| April 29, 2026 | 3.269B |
| April 28, 2026 | 3.302B |
| April 27, 2026 | 3.501B |
| April 24, 2026 | 3.417B |
| April 23, 2026 | 3.617B |
| April 22, 2026 | 3.672B |
| April 21, 2026 | 3.734B |
| April 20, 2026 | 3.888B |
| April 17, 2026 | 3.987B |
| April 16, 2026 | 3.817B |
| April 15, 2026 | 3.910B |
| April 14, 2026 | 3.960B |
| April 13, 2026 | 4.168B |
| April 10, 2026 | 3.997B |
| April 09, 2026 | 4.032B |
| April 08, 2026 | 3.910B |
| April 07, 2026 | 3.899B |
| April 06, 2026 | 3.923B |
| April 02, 2026 | 3.793B |
| April 01, 2026 | 3.772B |
| March 31, 2026 | 3.680B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ProQR Therapeutics NV | 148.56M |
| Pharming Group NV | 861.32M |
| Damora Therapeutics, Inc. | 1.215B |
| Dyne Therapeutics, Inc. | 2.919B |
| ACADIA Pharmaceuticals, Inc. | 3.636B |
Market Cap Related Metrics
| PS Ratio | 153.92 |
| Price to Book Value | 5.143 |
| Price | 29.33 |
| Earnings Yield | -6.15% |